Technology provides non-invasive treatment for congenital heart disease patients
WASHINGTON, D.C., (April 30, 2021) – New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract…
Details